Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Announcement Summary
For personal use only
Entity name
MEDIBIO LIMITED
Date of this announcement
Tuesday January 18, 2022
The +securities the subject of this notification are:
Other
Total number of +securities to be issued/transferred
Total number of | |||
ASX +security | +securities to be | ||
code | Security description | issued/transferred | Issue date |
MEBAD | OPTION EXPIRING VARIOUS DATES EX | 2,000,000 | 18/01/2022 |
VARIOUS PRICES |
Refer to next page for full details of the announcement
Notification of Issue, Conversion or Payment up of Unquoted | 1 / 7 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 1 - Entity and announcement details
For personal use only
1.1 Name of entity
MEDIBIO LIMITED
We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.
1.2 | Registered number type | Registration number |
ABN | 58008130336 | |
1.3 | ASX issuer code | |
MEB |
- The announcement is New announcement
- Date of this announcement
18/1/2022
Notification of Issue, Conversion or Payment up of Unquoted | 2 / 7 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 2 - Issue details
For personal use only
2.1 The +securities the subject of this notification are: Other
Please specify
Unlisted options granted to members of the Company's Growth & Advocacy Advisory Board as fees.
2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:
has an existing ASX security code ("existing class")
Notification of Issue, Conversion or Payment up of Unquoted | 3 / 7 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 3B - number and type of +securities the subject of this notification (existing class) where issue has not previously been notified to
ASX in an Appendix 3B
For personal use only
Additional +securities in an existing class
ASX +security code and description
MEBAD : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
Date the +securities the subject of this notification were issued
18/1/2022
Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class
Yes
Any other information the entity wishes to provide about the +securities the subject of this notification
Unlisted options granted to members of the Company's Growth & Advocacy Advisory Board (GAAB) as fees for participation in the GAAB.
Please provide any further information needed to understand the circumstances in which you are notifying the issue of these +securities to ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B
N/A
Notification of Issue, Conversion or Payment up of Unquoted | 4 / 7 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Issue details
For personal use only
Number of +securities
2,000,000
Were the +securities issued for a cash consideration?
No
Please describe the consideration being provided for the +securities
The securities are being issued as fees for services provided in relation to the GAAB.
Purpose of the issue
To pay for services rendered
Additional Details
The Option have an exercise price of $0.01 (1 cent) per option and will expire on 1 October 2025.
Notification of Issue, Conversion or Payment up of Unquoted | 5 / 7 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Medibio Limited published this content on 18 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 January 2022 03:14:04 UTC.